Fungal Infections

Skip to main content

Narrative Reviews

Fungal Infections

Image: Shutterstock / David A Litman

Major Sepsis Trials | Major Sepsis Guidelines

Sections

General | Monitoring & Investigations | Therapies

General

General

Mercier. Clinical considerations in the early treatment of invasive mould infections and disease. J Antimicrob Chemother 2017;72(suppl_1):i29–i38
Bassetti. Invasive mould infections in the ICU setting: complexities and solutions. J Antimicrob Chemother 2017;72(suppl_1):i39–i47

Background

Epidemiology

Lass-Flörl. Changes in the epidemiological landscape of invasive mould infections and disease. J Antimicrob Chemother 2017;72(suppl_1):i5–i11

Conditions

Liver Disease

Epelbaum. Invasive fungal infections in patients with liver disease: immunological and clinical considerations for the intensive care unit. Intensive Care Med 2025;epublished February 17th

COVID-19

Choudhury. COVID-19-Associated Fungal Co-Infections: Pathogenesis, Diagnostics, Biomarkers, and Therapeutic Strategies. J Clin Med 2026;15(17):6896

Complications

Complication

Monitoring & Investigations

General

Lamoth. Early diagnosis of invasive mould infections and disease. J Antimicrob Chemother 2017;72(suppl_1):i19–i28

Imaging

Lai. Radiotracer Development for Fungal-Specific Imaging: Past, Present, and Future. J Infect Dis 2023;228(Supplement_4):S259–S269

Drug Levels

Stott. Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations. J Antimicrob Chemother 2017;72(suppl_1):i12–i18

Therapies

General

Ledoux. New pharmacological opportunities for the treatment of invasive mould diseases. J Antimicrob Chemother 2017;72(suppl_1):i48–i58

Prophylaxis

Sprute. Antifungal prophylaxis and pre-emptive therapy: When and how? Mol Aspects Med 2023;92:101190

Last updated September 10th, 2026